Separate product status from seller status
Search the exact medicine or regulatory product record first, then verify the pharmacy, professional, or establishment identity through the separate national, state, or provincial record.
North America / 2 country guides
Peptides in North America: keep United States and Canadian records separate.
The United States and Canada share a border and many search results, but not one medicine, pharmacy, compounding, import, or research-product system. This map keeps both verification paths visible and separate.
Regional boundary
One map, distinct national records.
A seller may quote North American shipping, US testing, Canadian fulfillment, or cross-border availability while the exact product and supply route fall under different records. Product authorization, pharmacy authority, compounding status, research labeling, and import are separate checks in both countries.
Verification sequence
Three checks before any regional comparison.
Use the same sequence in every country, while allowing the authority, terminology, available fields, and legal route to change.
Follow the destination jurisdiction
Use United States federal and state records for US supply, or Health Canada and the relevant provincial college for Canadian supply. A record across the border is not a substitute.
Keep research listings outside medicine rankings
A laboratory-research catalog, approved prescription medicine, compounded preparation, clinic service, and imported product answer different questions and should not be normalized into one best-seller list.
Direct answers
What this regional map can and cannot answer.
These answers preserve the country boundary and point to the source map below. They are not medical or legal advice.
Are peptide products regulated the same way in the United States and Canada?
No. The countries use different federal product systems and different pharmacy oversight structures. The exact destination, product category, seller identity, and supply route determine which linked records must be checked.
Does shipping from the United States prove a peptide can be supplied in Canada?
No. Shipping origin does not establish Canadian product authorization, import eligibility, prescription status, pharmacy authority, or provincial registration. The Canadian guide links the relevant federal and provincial starting points.
Does Peptide Local mix US research prices with Canadian medicine prices?
No. US laboratory-research price boards remain in their own category. This regional map does not combine them with Canadian pharmacies, clinics, prescription medicines, compounded products, or import routes.
Tracked compound routes
41 peptide records, one country boundary.
These direct answers resolve the identity and status lane first. Select a destination country before drawing any conclusion about authorization, supply, or a seller.
KPV in North America
KPV in North America is tracked as an FDA-reviewed unapproved peptide identity with preclinical evidence and no identified human administration study. This is not a region-wide authorization, availability, benefit, safety, or supply finding. Choose a destination country and verify its exact product and seller records.
BPC-157 in North America
BPC-157 in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
TB-500 in North America
TB-500 in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
GHK-Cu in North America
GHK-Cu in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Semax in North America
Semax in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Melanotan II in North America
Melanotan II in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
MOTS-c in North America
MOTS-c in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Tesamorelin in North America
Tesamorelin in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
AOD-9604 in North America
AOD-9604 in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Ipamorelin in North America
Ipamorelin in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Selank in North America
Selank in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
PT-141 / Bremelanotide in North America
PT-141 / Bremelanotide in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
CJC-1295 no DAC in North America
CJC-1295 no DAC in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
CJC-1295 DAC in North America
CJC-1295 DAC in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Retatrutide in North America
Retatrutide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Mazdutide in North America
Mazdutide has NMPA approvals in China, not a region-wide or worldwide approval for North America. Verify the destination country's current product and seller records before treating any offer as authorized or available.
Ecnoglutide in North America
Ecnoglutide has NMPA approvals in China, not a region-wide or worldwide approval for North America. Verify the destination country's current product and seller records before treating any offer as authorized or available.
Enicepatide in North America
Enicepatide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Eloralintide in North America
Eloralintide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Cagrilintide in North America
Cagrilintide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Petrelintide in North America
Petrelintide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
CagriSema in North America
CagriSema in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
MariTide in North America
MariTide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Survodutide in North America
Survodutide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
VK2735 in North America
VK2735 in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Pemvidutide in North America
Pemvidutide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Amycretin / Zenagamtide in North America
Amycretin / Zenagamtide in North America refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Tirzepatide in North America
Tirzepatide in North America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Orforglipron / Foundayo in North America
Orforglipron / Foundayo in North America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Semaglutide in North America
Semaglutide has distinct US and Canadian product records, including new Canadian generic authorizations in 2026. Brand, indication, presentation, prescription status, supply, and seller authority must still match the destination's exact records.
DSIP / Emideltide in North America
DSIP / Emideltide in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
IGF-1 LR3 in North America
IGF-1 LR3 in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Kisspeptin-10 / KP-10 in North America
Kisspeptin-10 / KP-10 in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Melanotan I in North America
Melanotan I in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
NAD+ in North America
NAD+ in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Sermorelin in North America
Sermorelin in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Thymosin Alpha-1 in North America
Thymosin Alpha-1 in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
EGRIFTA WR in North America
EGRIFTA WR in North America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Liraglutide in North America
Liraglutide in North America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
SCENESSE in North America
SCENESSE in North America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
VYLEESI in North America
VYLEESI in North America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Country record map
2 destinations, each with its own source trail.
Open the first source for the product question and the second source for the seller, pharmacy, establishment, or supply question. Read the full country guide for the exact boundary.
01Category-dependent
Peptides in the United States (USA)
English · July 18, 2026A national guide to separating state-licensed pharmacy access, federal compounding records, approved-drug information, and laboratory-research listings before comparing price.
- Comparison mode
- USD / normalized per mg
- Current price coverage
- 78 US listings / 20 boards
Product recordDrugs@FDA approved drug databaseU.S. Food and Drug Administration ↗Seller or supply recordLocate a state-licensed online pharmacyU.S. Food and Drug Administration ↗
Read the United States guide →02Health Canada warning
Peptides in Canada
English · July 18, 2026A Canada-specific verification guide built around Health Canada’s peptide warning, the Drug Product Database, and provincial pharmacy licensing.
- Comparison mode
- DIN / pharmacy / CAD cost
- Current price coverage
- No sellers ranked
Product recordDrug Product DatabaseHealth Canada ↗Seller or supply recordChoosing a safe online pharmacyHealth Canada ↗
Read the Canada guide →Publishing gate
No region-wide seller table yet.
Peptide Local will publish regional commercial comparisons only when every row has a sourced seller category, product status, destination market, comparable price, evidence route, and observation date. The current page compares official verification paths.